Farm Comunitarios. 2023 Oct 16;15(4):13-25. doi: 10.33620/FC.2173-9218.(2023).27

Blood pressure measurement campaign (May Measurement Month) 2019: Analysis of screening in spanish community pharmacies and detection of masked hypertension

Mera-Gallego I1, Tous i Trepat S2, Prats-Mas R3, Molinero A4, Fornos-Pérez JA5, Andrés-Rodríguez NF6
1. Member of the SEFAC Diabetes group. Community pharmacy in Maella (Zaragoza) 2. Member of the HTA and RV group at SEFAC. Community pharmacist in Igualada (Barcelona) 3. Doctor of Pharmacy. Community pharmacy in Denia (Alicante) 4. Doctor of Pharmacy. Member of the HTA group and RV from SEFAC. Associate Professor UAH. Community pharmacy in Fuenlabrada (Madrid) 5. Doctor of Pharmacy. Member of the SEFAC Diabetes group. USC Associate Professor. Community pharmacist in Cangas do Morrazo (Pontevedra) 6. Doctor of Pharmacy. Member of the SEFAC Diabetes group
Mera-Gallego I, Tous S, Prats-Mas R, Molinero A, Fornos-Pérez JA, Andrés-Rodríguez NF. Blood pressure measurement campaign (May Measurement Month) 2019: Analysis of screening in spanish community pharmacies and detection of masked hypertension. Farm Comunitarios. 2023 Oct 16;15(4):13-25. doi: 10.33620/FC.2173-9218.(2023).27
Abstract : 

Aim: To learn about the situation of body pressure (BP) in the Spanish population within the May Measurement Month project, to disseminate the importance of its periodic measurement, and to estimate the prevalence of masked hypertension.

Methods: Cross-sectional descriptive study in Spanish community pharmacies during May 2019. Adult users who consented to participate.

Variables: systolic blood pressure, diastolic blood pressure in millimeters of mercury (mm Hg), heart rate (HR) in beats/minute (beats/min).

Participants with BP ≥130/85 and <149/90 were offered confirmation of values by Home Blood Pressure Monitoring (HBPM) to confirm masked hypertension.

Results: 3402 valid records made by 491 pharmacists. 61.9% women, mean age 56.6 years. 143 (4.2%) had never measured BP and 918 (27.0%) had not measured BP in the last year. 1047 were taking antihypertensive drugs, 45.7% of whom had high BP.

780 (22.9%) participants had elevated BP values;both 252 (7.4%). Systolic mBP was 125.0, diastolic mBP 76.5 mm Hg, higher in men (p<0.001). The mHR was 72.6 beats/min.

A direct relationship was found between systolic and diastolic BP and BMI (p<0.0001). Diastolic BP and HR were higher in smokers (p<0.0001). In diabetic patients, systolic BP, diastolic BP and HR were higher.

61 participants with suspected masked hypertension agreed to undergo HBPM. 25 (40.1%) had BP ≥135/85 mmHg.

Conclusions: Nearly one in four participants had BP values ≥140/90 mmHg. The risk factors most closely related to elevated BP were overweight, diabetes, and age. Forty percent of suspected masked hypertension were confirmed by HBPM.

Article download link: 

Editor: © SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. 
Copyright© SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. This article is available from url https://www.farmaceuticoscomunitarios.org/. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en

Share

-

Manual for authors

Journal Information